Viewing Study NCT02311933


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2026-03-05 @ 9:31 AM
Study NCT ID: NCT02311933
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-10
First Post: 2014-12-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Breast Carcinoma View
None Stage III Breast Cancer AJCC v7 View
None Stage IIIA Breast Cancer AJCC v7 View
None Stage IIIB Breast Cancer AJCC v7 View
None Stage IIIC Breast Cancer AJCC v7 View
None Stage IV Breast Cancer AJCC v6 and v7 View
Keywords: